Study shows frequently used serology test may not detect antibodies that could confirm protection against reinfection of COVID-19

Published in JCI Insight · View the paper (DOI)

Researchers at MD Anderson Cancer Center found that some commercially available serological tests only detect N-protein antibodies, which may not indicate immunity to reinfection. S-RBD antibody detection is considered a better indicator of protection against COVID-19 reinfection.

Study shows frequently used serology test may not detect antibodies that could confirm protection against reinfection of COVID-19

Coverage from 2 institutions